Mechanism of the Decrease in Catalytic Activity of Human Cytochrome P450 2C9 Polymorphic Variants Investigated by Computational Analysis

被引:40
|
作者
Sano, Eri [1 ]
Li, Weihua [1 ]
Yuki, Hitomi [1 ]
Liu, Xinli [1 ]
Furihata, Tomomi [2 ]
Kobayashi, Kaoru [2 ]
Chiba, Kan [2 ]
Neya, Saburo [1 ]
Hoshino, Tyuji [1 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Phys Chem, Chiba 2638522, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Chiba 2608675, Japan
基金
日本学术振兴会;
关键词
cytochrome P450; polymorphism; enzymatic activity; molecular dynamics; docking simulation; MOLECULAR-DYNAMICS SIMULATION; FORCE-FIELD PARAMETERS; MONOOXYGENATION MECHANISM; POSSIBLE PATHWAY(S); FLEXIBLE DOCKING; HIV-1; PROTEASES; BINDING MODES; IN-VITRO; SITE; CYP2C9;
D O I
10.1002/jcc.21568
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cytochrome P450 (CYP) is deeply involved in the metabolism of chemicals including pharmaceuticals. Therefore, polymorphisms of this enzyme have been widely studied to avoid unfavorable side effects of drugs in chemotherapy. In this work, we performed computational analysis of the mechanism of the decrease in enzymatic activity for three typical polymorphisms in CYP 2C9 species: *2, *3, and *5. Based on the equilibrated structure obtained by molecular dynamics simulation, the volume of the binding pocket and the fluctuation of amino residues responsible for substrate holding were compared between the wild type and the three variants. Further docking simulation was carried out to evaluate the appropriateness of the binding pocket to accommodate substrate chemicals. Every polymorphic variant was suggested to be inferior to the wild type in enzymatic ability from the structural viewpoint. F-G helices were obviously displaced outward in CYP2C9*2. Expansion of the binding pocket, especially the space near F' helix, was remarkable in CYP2C9*3. Disappearance of the hydrogen bond between K helix and beta 4 loop was observed in CYP2C9*5. The reduction of catalytic activity of those variants can be explained from the deformation of the binding pocket and the consequent change in binding mode of substrate chemicals. The computational approach is effective for predicting the enzymatic activity of polymorphic variants of CYP. This prediction will be helpful for advanced drug design because calculations forecast unexpected change in drug efficacy for individuals. (C) 2010 Wiley Periodicals, Inc. J Comput Chem 31: 2746-2758, 2010
引用
收藏
页码:2746 / 2758
页数:13
相关论文
共 50 条
  • [1] Metabolism of steroids by cytochrome P450 2C9 variants
    Uno, Tomohide
    Nakano, Ryosuke
    Kitagawa, Risa
    Okada, Mai
    Kanamaru, Kengo
    Takenaka, Shinji
    Uno, Yuichi
    Imaishi, Hiromasa
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (08) : 371 - 377
  • [2] Human Cytochrome P450 2C9 and Its Polymorphic Modifications: Electroanalysis, Catalytic Properties, and Approaches to the Regulation of Enzymatic Activity
    Shumyantseva, Victoria V.
    Bulko, Tatiana V.
    Koroleva, Polina I.
    Shikh, Evgeniya V.
    Makhova, Anna A.
    Kisel, Maryia S.
    Haidukevich, Irina V.
    Gilep, Andrei A.
    PROCESSES, 2022, 10 (02)
  • [3] Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations
    Cho, Myung-A
    Yoon, Jihoon G.
    Kim, Vitchan
    Kim, Harim
    Lee, Rowoon
    Lee, Min Goo
    Kim, Donghak
    BIOMOLECULES & THERAPEUTICS, 2019, 27 (06) : 577 - 583
  • [4] Metabolism of 7-ethoxycoumarin, flavanone and steroids by cytochrome P450 2C9 variants
    Uno, Tomohide
    Nakano, Ryosuke
    Kanamaru, Kengo
    Takenaka, Shinji
    Uno, Yuichi
    Imaishi, Hiromasa
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (08) : 486 - 493
  • [5] Role of Residue 90 in Catalysis of Cytochrome P450 2C9
    Wang Ying
    Zhou Yi-han
    Guo Ying-jie
    Xu Xue-lian
    Si Da-yong
    Zhou Hui
    Li Ze-sheng
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2009, 25 (06) : 904 - 908
  • [6] Clinical Drugs Undergoing Polymorphic Metabolism by Human Cytochrome P450 2C9 and the Implication in Drug Development
    He, S. -M.
    Zhou, Z. -W.
    Li, X. -T.
    Zhou, S. -F.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (05) : 667 - 713
  • [7] MODELING COMPLEXES OF SUBSTRATES WITH CYTOCHROME P450 2C9
    Pogrebnoi, A. A.
    Grishina, M. A.
    Potemkin, V. A.
    Sysakov, D. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2010, 44 (05) : 237 - 240
  • [8] Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal Adenoma
    Chan, Andrew T.
    Zauber, Ann G.
    Hsu, Meier
    Breazna, Aurora
    Hunter, David J.
    Rosenstein, Rebecca B.
    Eagle, Craig J.
    Hawk, Ernest T.
    Bertagnolli, Monica M.
    GASTROENTEROLOGY, 2009, 136 (07) : 2127 - 2136
  • [9] Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism
    Chen, Mengchun
    Zhang, Youting
    Pan, Peipei
    Wang, Li
    Zhan, Yunyun
    Jin, Hui
    Xia, Mengmin
    Wang, Xianqin
    Dai, Dapeng
    Cai, Jianping
    Hu, Guoxin
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (11) : 1820 - 1825
  • [10] Role of Residue 90 in Catalysis of Cytochrome P450 2C9
    WANG Ying1
    ChemicalResearchinChineseUniversities, 2009, 25 (06) : 904 - 908